Table 2. Enzymes, efflux pumps, and mutations expected to confer resistance to antibiotics of clinical relevancea.
Enzymeb | Gene location(s) | Coordinates | Resistance phenotype |
NDM-1 (class B) | pNDM-US Tn125 | 122191–123003 | Penicillins, cephalosporins, carbapenems, inhibitor-resistant |
SHV-11 (class A)c | 1. pKpn2146b | 36313–37173 | Penicillins, some cephalosporins, inhibitor-sensitive |
2. Chromosome | 2612996–2613856 | ||
CTX-M-15 (class A) | 1. pKpn2146b ISEcp1 | 47130–48005 | Penicillins, some cephalosporins, aztreonam, |
2. Chromosome ISEcp1 | 5407530–5408405 | inhibitor-sensitive | |
TEM-1 (class A) | pKpn2146b Tn2 | 50827–51687 | Penicillins, some cephalosporins, inhibitor-sensitive |
CMY-6 (class C) | pNDM-US ISEcp1 | 72203–73348 | Penicillins, some cephalosporins, inhibitor-resistant |
OXA-1 (class D) | pKpn2146b ΔIn37 | 38798–39673 | Penicillins, inhibitor-resistant |
AAC(3)-IIe | pKpn2146b | 41116–41976 | Gentamicin, tobramycin, netilmicin, sisomicin |
AAC(6′)-Ib (43) | pNDM-US In46 | 115114–115737 | Tobramycin, amikacin, netilmicin, sisomicin |
AAC(6′)-Ib (1) | pKpn2146b ΔInTn1331 | 82745–83350 | Tobramycin, amikacin, netilmicin, sisomicin |
AAC(6′)-Ib-cr (29) | pKpn2146b ΔIn37 | 38113–38712 | Tobramycin, amikacin, netilmicin, sisomicin, quinolones (low-level) |
ANT(3″)-Ia | Kpn23SapB In127 | 2297711–2298502 | Streptomycin, spectinomycin |
APH(3″)-Ib (StrA) | pKpn2146b ISCR2 | 53244–54047 | Streptomycin |
APH(6)-Id (StrB) | pKpn2146b ISCR2 | 52408–53238 | Streptomycin |
Sul2 | pKpn2146b ISCR2 | 54108–54923 | Sulfonamides |
RmtC | pNDM-US ISEcp1 | 120100–120945 | Aminoglycosides (via rRNA modification) |
Sul1 | 1. Kpn23SapB In127 | 2299007–2299846 | Sulfonamides |
2. pNDM-US In46 | 116245–117084 | ||
DfrA14 | pKpn2146b In191 | 8281–8754 | Trimethoprim |
QnrB9 | pKpn2146b | 26074–26742 | Quinolones, fluoroquinolones |
Mph(A) | pKpn2146c | 16503–17408 | Macrolides, Erythromycin |
FosA | Chromosome | 667960–668379 | Fosfomycin |
Efflux pump | Gene Location | Probable substrate(s)d | |
AcrAB-TolC | Chromosome | 1249681–1254043 | Aminoglycosides, β-lactams, tigecycline, macrolides |
AcrEF-TolC | Chromosome | 4936203–4940465 | Minor role |
EefABC | Chromosome | 5354323–5329922 | Chloramphenicol, tetracyclines, ciprofloxacin |
MacAB-TolC | Chromosome | 1857393–1860445 | Macrolides |
MdfA | Chromosome | 1781588–1782820 | Aminoglycosides, fluoroquinolones, chloramphenicol |
MdtG,H,K,L,M,NOP | Chromosome | e | Many possible substrates (MFS superfamily pumps) |
OqxAB | Chromosome | 4169609–4173960 | Chloramphenicol, fluoroquinolones, trimethoprim |
EmrAB | Chromosome | 4218886–4221612 | Nalidixic acid, hydrophobic compounds |
TetA(A) | pKpn2146c Tn1721 | 19168–20367 | Tetracyclines |
Gene | Mutation | Resistance phenotype | |
gyrA Gyrase | Ser83TTC → IleATC | 3763583–3766216 | Quinolone, fluoroquinolones |
parC Topo IV | Ser80AGC → IleATC | 4689294–4691552 | Quinolone, fluoroquinolones |
nfsA Nitroreductase | Frameshift | 1826275–1826998 | Nitrofurantoin |
Excluding the resistance enzyme for bleomycin, an antibiotic used clinically only as an antitumor agent.
Two silent differences between the two copies.
Probable efflux substrates identified from literature sources including ARDB; the substrates list is not comprehensive and in many cases has been deduced from organisms other than K. pneumoniae.
Mdt genes are scattered over the chromosome.